The 6th International Symposium on Amphibian and Reptilian Endocrinology and Neurobiology (ISAREN), the former International Symposium on Amphibian Endocrinology (ISAE), was recently held in Berlin. ISAREN developed from two symposia on amphibian biology held in European countries in 1988-1990. In this article, the history of ISAREN was briefly stated. In addition, some of the topics of our researches carried out in collaboration with several groups, using various amphibian species during the past 20 years and/or presented in the past symposia were reviewed. The topics included the discovery of pancreatic chitinase, involvement of growth hormone in vitellogenin synthesis, changes of ANF-like immunoreactivity in the frogs sent into the space, discovery of a peptide sex-pheromone, origin of the epithelial pituitary, and hypothalamic regulation of thyroid-stimulating hormone.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ygcen.2010.01.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oocyte donors' physical outcomes and psychosocial experiences: a mixed-methods study.
Fertil Steril
January 2025
Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, Michigan.
Objective: To expand knowledge on physical outcomes and psychosocial experiences of oocyte donors after donation across 3 age cohorts.
Design: Cross-sectional mixed-methods survey.
Patients: A total of 363 participants (ages: 22-71 years, M = 38.
Diagnostic accuracy of screening tests for eating disorders in adolescents and adults in primary health care: protocol for systematic review and meta-analysis.
BMJ Open
December 2024
School of Nutrition, Federal University of Bahia, Salvador, Brazil.
Introduction: Eating disorders can be irreversible and, in many cases, fatal. However, the symptoms full recovery is possible, and early diagnosis is one, of many, important factors for the success of treatment. In this sense, the screening of risk behaviours arises as a relevant alternative to improve the prognosis of patients.
View Article and Find Full Text PDFMycoNews 2023: Editorial, news, reports, awards, personalia, and book news.
IMA Fungus
February 2024
Trait Diversity and Function, Royal Botanic Gardens, Kew, Surrey TW9 3DS UK.
This fifth annual edition of starts with an editorial on the critical importance of International Mycological Congresses (IMCs) to the health of mycology. Items on Counting down to IMC12, the State of the World's Plants and Fungi 2023, and progress towards Improving nomenclatural stability in medically important fungi follow. Reports are provided of several mycological meetings in 2023: the Asian Mycological Congress, XIX Congress of European Mycologists, a meeting of European Mycological Groups and Societies, the XI Latin American Mycological Congress, Westerdijk Spring Symposium on Fungal Evolution, the Brazilian Society of Mycology, the Annual Meeting of the Mycological Society of China, and the Fifth Iranian Mycological Congress.
View Article and Find Full Text PDFTreatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials.
Ther Adv Med Oncol
January 2025
Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Alessandro Manzoni 56, 20089 Rozzano, Italy.
Objectives: A combination of chemotherapy and radiotherapy is employed in the curative and postoperative treatment of locally advanced head and neck cancers (HNC). Integrated chemoradiation (CRT) treatments result in a non-negligible rate of severe toxic effects. Treatment-related death (TRD) is a crucial topic for physicians involved in the curative treatment of HNC.
View Article and Find Full Text PDFA phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.
Gynecol Oncol
January 2025
Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Introduction: Molecular alterations in the PI3K/AKT and Ras/Raf/MEK/ERK pathways are frequently observed in patients with endometrial cancers. However, mTOR inhibitors, such as temsirolimus, have modest clinical benefits. In addition to inducing metabolic changes in cells, metformin activates AMPK, which in turn inhibits the mTOR pathway.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!